We are live on ! Find out more
HM

Howard Marks Oaktree Capital Management

AUM $7.21B
1-Year Est. Return 45.97%
 

Howard Marks is co-founder of Oaktree Capital Management, a leading firm in credit, distressed debt, and alternative credit strategies. He is equally well known for his widely read client memos on market cycles, risk, and investor psychology. Marks’s investing philosophy stresses second-level thinking, asymmetric risk/reward, and the importance of understanding where markets sit in the credit cycle.

This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+45.97%
3 Year Est. Return
+88.04%
5 Year Est. Return
+157.91%
10 Year Est. Return
+691.44%
AUM
$7.03B
AUM Growth
+$538M
Cap. Flow
-$9.02B
Cap. Flow %
-128.29%
Top 10 Hldgs %
43.61%
Holding
182
New
7
Increased
8
Reduced
23
Closed
10

Top Sells

Rank Stock Value
1
INDV icon
Indivior Pharmaceuticals
INDV
+$7.65B
2
TRMD icon
TORM
TRMD
+$299M
3
GTX icon
Garrett Motion
GTX
+$236M
4
CX icon
Cemex
CX
+$48.6M
5
VIST icon
Vista Energy
VIST
+$47.9M

Sector Composition

Rank Sector Weight
1 Energy 19.94%
2 Materials 9.78%
3 Communication Services 5.76%
4 Technology 5.39%
5 Financials 5.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHC icon
51
Bausch Health
BHC
$2.41B
$8.83M 0.13%
1,270,000
MX icon
52
Magnachip Semiconductor
MX
$121M
$7.27M 0.1%
2,849,858
LILA icon
53
Liberty Latin America Class A
LILA
$1.66B
$6.2M 0.09%
1,235,037
-10,973
-0.9% -$60.6K
HDB icon
54
HDFC Bank
HDB
$121B
$4.77M 0.07%
130,441
-20,765
-14% -$747K
BATL icon
55
Battalion Oil
BATL
$77.9M
$3.4M 0.05%
3,009,912
-3,911
-0.1% -$4.48K
ALVOW icon
56
Alvotech Warrant
ALVOW
$66.4M
$3.03M 0.04%
4,666,667
ALVO icon
57
Alvotech
ALVO
$1.5B
$2.02M 0.03%
533,656
-1,030,020
-66% -$6.51M
BTAI icon
58
BioXcel Therapeutics
BTAI
$25.2M
$386K 0.01%
241,188
KRSP.WS
59
Rice Acquisition Corp Warrants
KRSP.WS
$320K ﹤0.01%
+399,999
New +$359K
ACR
60
ACRES Commercial Realty
ACR
$105M
-391,380
Closed -$8.28M
IWM icon
61
PUT
iShares Russell 2000 ETF
IWM
$81.9B
-220,000
Closed -$53.2M
NBR icon
62
Nabors Industries
NBR
$1.37B
-737,112
Closed -$30.1M
ECHO
63
EchoStar
ECHO
$25.2B
-600,000
Closed -$45.8M
SE icon
64
Sea Limited
SE
$72B
-141,368
Closed -$25.3M
TGS icon
65
Transportadora de Gas del Sur
TGS
$4.23B
-56,522
Closed -$1.19M
TPIC
66
DELISTED
TPI Composites
TPIC
-4,610,003
Closed -$143K
WING icon
67
PUT
Wingstop
WING
$3.14B
-50,000
Closed -$12.6M
JBS
68
JBS N.V.
JBS
$45.5B
-1,580,400
Closed -$23.6M
LGN
69
Legence Corp
LGN
$4.57B
-175,000
Closed -$5.39M

Similar funds

Howard Marks's Q4 2025 Portfolio in Review

As of Q4 2025, Howard Marks held 182 positions worth $7.03B, up 8.3% from $6.49B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Howard Marks withdrew a net $9.02B in Q4 2025, closing 10 positions and reducing 23 holdings. Its most notable exit was EchoStar, an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Energy at 20% of assets, down from 27% a quarter earlier, followed by Materials and Communication Services.

Against the trend, Howard Marks opened a new position in Grupo Aeromexico SAB de CV worth $82.9M.

  • Howard Marks's largest Q4 2025 buy was Grupo Aeromexico SAB de CV: 3,776,986 shares worth $82.9M.
  • Howard Marks added most to Core Scientific in Q4 2025, an estimated $34M increase.
  • Howard Marks's biggest Q4 2025 reduction was Indivior Pharmaceuticals, cutting an estimated $7.65B.
  • Howard Marks fully exited EchoStar in Q4 2025, selling an estimated $45.8M.
  • Howard Marks's ten largest holdings make up 44% of its $7.03B portfolio in Q4 2025.
  • Howard Marks opened 7 new positions and closed 10 in Q4 2025.
  • Howard Marks's portfolio value rose 8.3% quarter-over-quarter to $7.03B.

Based on Oaktree Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.